| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/16/2001 | CA2399945A1 Larynx carcinoma-associated protein larcap-1 |
| 08/16/2001 | CA2399944A1 Novel use of pulmonary surfactant for the prophylaxis and treatment of chronic pulmonary diseases |
| 08/16/2001 | CA2399939A1 Partners of ptb1 domain of fe65, preparation and uses |
| 08/16/2001 | CA2399873A1 Drug metabolizing enzymes |
| 08/16/2001 | CA2399640A1 Selective n-acylation of a82846 glycopeptide analogs |
| 08/16/2001 | CA2399593A1 Antibodies to ccr5 |
| 08/16/2001 | CA2399452A1 Use of neuregulin-.beta. as an indicator and/or target |
| 08/16/2001 | CA2399436A1 Method of treating or inhibiting cellular injury or cell death |
| 08/16/2001 | CA2399391A1 Trade molecules and uses related thereto |
| 08/16/2001 | CA2399387A1 Heterologous polypeptide of the tnf family |
| 08/16/2001 | CA2399126A1 Extraction of zein protein from gluten meal |
| 08/16/2001 | CA2399019A1 Proteins producing an altered immunogenic response and methods of making and using the same |
| 08/16/2001 | CA2398984A1 Use of glutamate and/or a glutamate precursor for the preparation of a nutritional or pharmaceutical preparation for the treatment or prevention of hyperpermeability or undesired permeability of the intestinal wall |
| 08/16/2001 | CA2398822A1 Piperazine and piperidine derivatives |
| 08/16/2001 | CA2398775A1 Inhibitor of hepatocyte growth factor activator for use in modulation of angiogenesis and cardiovascularization |
| 08/16/2001 | CA2398750A1 Nucleozymes with endonuclease activity |
| 08/16/2001 | CA2398679A1 Aggregate-free urate oxidase for preparation of non-immunogenic polymer conjugates |
| 08/16/2001 | CA2398567A1 Methods for enhancing the bioavailability of a drug |
| 08/16/2001 | CA2398282A1 Method and reagent for the modulation and diagnosis of cd20 and nogo gene expression |
| 08/16/2001 | CA2397254A1 Interferon-alpha induced genes |
| 08/16/2001 | CA2392450A1 Nucleic acids, proteins, and antibodies |
| 08/16/2001 | CA2368681A1 Anti-angiogenic intestinal peptides, zdint5 |
| 08/16/2001 | CA2366522A1 Non-naturally occurring nucleic acid compositions, their use for the preparation of formulations useful for transfecting a nucleic acid into cells and applications |
| 08/15/2001 | CN1308740A Methods of determining protein activity levels usne expression profiles |
| 08/15/2001 | CN1308677A Human tumour-derived polyptde hormone phosphatonin |
| 08/15/2001 | CN1308676A Antibodies to CD23, derivatives thereof, and their therapeutic uses |
| 08/15/2001 | CN1308675A Immunological reagent specifically interating with the extracellular domain of the human zeta chain |
| 08/15/2001 | CN1308674A Multivalent T cell receptor complexes |
| 08/15/2001 | CN1308671A Myelin basic protein peptides and uses thereof |
| 08/15/2001 | CN1308637A Binding molecules derived from immunolobulins which do not trigger complement mediated lysis |
| 08/15/2001 | CN1308635A Novel cyclosporin with improved activity profile |
| 08/15/2001 | CN1308546A Immunomodulators for vaccines |
| 08/15/2001 | CN1308545A Method of increasing bone toughness and stiffness and reducing fractures |
| 08/15/2001 | CN1308544A Treatment for diabetes |
| 08/15/2001 | CN1308543A Oxidized thymosin beta 4 |
| 08/15/2001 | CN1308542A Sucoinamide inhibitors of interleukin-1& beta, converting enzyme |
| 08/15/2001 | CN1308540A Anti-diarrheal and method for using the same |
| 08/15/2001 | CN1308086A Antibiotic/antiendotoxic mimic peptide and its preparation and application |
| 08/15/2001 | CN1308078A Camptothecin derivative and its preparation |
| 08/15/2001 | CN1307900A Application of tigroid spider toxic extract in preparing analgesic |
| 08/15/2001 | CN1069544C Thebaica giving-up vaccinum for man |
| 08/14/2001 | US6274719 Polynucleotides and polypeptides of the glycopeptidase family; human streptococci microbe diseases targets for development of antibiotics; otitis media, conjunctivitis, pneumonia, bacteremia, meningitis, sinusitis, endocarditis |
| 08/14/2001 | US6274717 Diagnostic assays for detecting diseases associated with membrane-type matrix metalloproteinases 5-l activity and/or treatment of kidney-related, brain-related, cardiovascular diseases, inflammation and cancer |
| 08/14/2001 | US6274712 Muteins; cell division potent stimulators or superagonists; useful angiogenesis, wound healing, treating ischemia, gastric or duodenal ulcer, neural injury |
| 08/14/2001 | US6274711 Proteins and mimetics which function in regulating, controlling physiology, development, and differentiation of mammalian immune cells including hemopoietic type; cytotoxic t lymphocyte activated or associated antigen (ctla) |
| 08/14/2001 | US6274708 Mouse interleukin-11 receptor |
| 08/14/2001 | US6274706 Intron/exon of the human and mouse beta 3-adrenergic receptor genes |
| 08/14/2001 | US6274704 Peptides derived from the heparin binding domain of fibronectin |
| 08/14/2001 | US6274702 Bone stimulating factor |
| 08/14/2001 | US6274613 Cyclic imines as pesticides |
| 08/14/2001 | US6274582 Reduction of visceral fat |
| 08/14/2001 | US6274558 Purified hypothalamic inhibitory factor |
| 08/14/2001 | US6274557 Dipeptide containing nitroarginine or ester or amide derivative |
| 08/14/2001 | US6274556 Administering polypeptide derivative to treat inflammatory bowel disease and to prevent leukocyte infiltration into tissues |
| 08/14/2001 | US6274554 Method for preventing and treating hearing loss using a neurturin protein product |
| 08/14/2001 | US6274553 Method for stabilizing peptides and freeze-dried medicinal compositions containing peptides obtained by using the method |
| 08/14/2001 | US6274552 Targeting tissue with tumor necrosis factor mixed or bound to colloidal metal; anticarcinogenic agents, autoimmune diseases |
| 08/14/2001 | US6274551 Cytotoxic and antiviral compound |
| 08/14/2001 | US6274549 Administering genetically engineered human insulin with deletion or substitution |
| 08/14/2001 | US6274548 Pectic substance as a growth factor stabilizer |
| 08/14/2001 | US6274547 Methods comprising the use of human interleukin-11 receptor proteins |
| 08/14/2001 | US6274380 Cacnglike3 polynucleotides and expression systems |
| 08/14/2001 | US6274365 A carrier compound containing an active recombinant furin enzyme; gene therapy; treatment of cancer |
| 08/14/2001 | US6274364 An isolated protease present in healthy stratum corneum; therapy and treatment of afflictions such as eczema, rosacea, psoriasis, lichens, severe pruritus and ichthyosis |
| 08/14/2001 | US6274362 RGS-containing molecules and uses thereof |
| 08/14/2001 | US6274361 A polynucleotide encoding a polypeptide sequence for a peptidyl-trna hydrolase; diagnosis and therapy for staphylococcal infections; screening antibiotics, vaccines |
| 08/14/2001 | US6274359 Amino acid sequence; for recombinant production of enzyme and production of 1-alpha, 25-dihydroxyvitamin d3; prevention, diagnosis and treatment of osteoporosis |
| 08/14/2001 | US6274348 Methods for the preparation of positively charged proteins |
| 08/14/2001 | US6274347 Contacting antibody producing cells with fusion protein of extracellular portion of human leukocyte adhesion molecule-1 and constant region of human immunoglobulin g1, then isolating antibodies |
| 08/14/2001 | US6274344 Methods for recombinant microbial production of fusion proteins and BPI-derived peptides |
| 08/14/2001 | US6274342 Nucleotide sequence; diagnosis; antiinflammatory agents; recombinant culture production |
| 08/14/2001 | US6274338 Human c-Maf compositions and methods of use thereof |
| 08/14/2001 | US6274336 Producing three-dimensional structure of active site using computer program, displaying and superimposing three-dimensional representation of test compound onto active site, preparing test compound, and testing in biological assay |
| 08/14/2001 | US6274335 Method of treatment using recombinant human tissue plasminogen activator |
| 08/14/2001 | US6274333 Type-2 neurotensin receptor (NT-R2) |
| 08/14/2001 | US6274331 Using recombinant dna vectors which encode di-alpha or di-beta globin-like polypeptide having linker, transforming cells, screening for production by determining response to carbon monoxide, determining amino acid sequence of linker |
| 08/14/2001 | US6274327 Genereting antibody which preferentially binds enzymatic polypeptide; administer immunogen to animal and isolate antibody from animal |
| 08/14/2001 | US6274322 Transfection kit; for use as nucleotide sequence tool during genetic engineering |
| 08/14/2001 | US6274175 Prolonged release of GM-CSF |
| 08/14/2001 | US6274166 Transdermal delivery system |
| 08/14/2001 | US6274158 Administering recombinant human erythropoietin for therapy of bleeding from an organ or body part having benign or malignant lesions b |
| 08/14/2001 | US6274155 As absorbent with skin healing properties when incorporated into diapers, feminine hygiene products, wound dressings, including both human and veterinary uses, as soft tissue augmentation medium when used in subdermal implants; cosmetics |
| 08/14/2001 | US6274148 Hepatitis C virus asialoglycoproteins |
| 08/14/2001 | US6274145 To generate cytolytic t cells against abnormal cells; as markers for pathological or abnormal condition in diagnosis |
| 08/14/2001 | US6274142 Neutralizing coagulant activity of tissue factor by administering antibody which binds to tissue factor protein and neutralizes |
| 08/14/2001 | US6274141 For feeding infants; enables immune system of an infant to distinguish between abbos protein sections and p69 protein sections and reduces risk that an infant will develop diabetes |
| 08/14/2001 | US6274140 Calcium independent cytosolic phospholipase A2/B enzymes |
| 08/14/2001 | US6274139 For therapy of bacterial infections |
| 08/14/2001 | US6274138 Human mitochondrial malate dehydrogenase |
| 08/14/2001 | US6274136 Construction and use of genes encoding pathogenic epitopes for treatment of autoimmune disease |
| 08/14/2001 | US6274135 Treating inflammation associated with acute pancreatitis by administering interleukin-11 to reduce inflammation |
| 08/14/2001 | US6274134 Human cell adhesion protein AAMP-1 and uses thereof |
| 08/14/2001 | US6274117 Cytokines that bind the cell surface receptor Hek |
| 08/14/2001 | US6274090 Apparatus and method of preparation of stable, long term thrombin from plasma and thrombin formed thereby |
| 08/14/2001 | CA2243570C Mixture of recombinant vaccinia vectors as polyenv vaccines for hiv |
| 08/14/2001 | CA2206824C Inhibitors of rotamase enzyme activity |
| 08/14/2001 | CA2185155C Therapeutic uses of bactericidal/permeability-increasing protein dimer products |
| 08/14/2001 | CA2180464C Enteral formula with ribo-nucleotides |
| 08/14/2001 | CA2037959C Cyclohexapeptides compound |
| 08/14/2001 | CA2012312C Genetic units for inhibiting the function of rna |